https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
g. Angpt-2/Angpt-1) leading to profound endothelial activation and leakage in ex vivo assays. CONCLUSION This is the first reported use of cytokine adsorption for CRS showing efficacy in absorption of various cytokines but not endothelial growth factors. A randomized controlled trial to evaluate additional Cytosorb treatment in CRS is currently recruiting at our institution (NCT04048434). BACKGROUND Pressure injuries are frequently occurred adverse events in hospitals, affecting the well-being of patients and causing c